Neurocrine Biosciences, Inc.

Filed a patent for "methods for the administration of certain vmat2 inhibitors" on Thu, August 17, 2023

Filed a patent for "methods for the administration of certain vmat2 inhibitors" on Thu, August 17, 2023

Filed a patent for "methods for the administration of certain vmat2 inhibitors" on Fri, October 13, 2023

Filed a patent for "methods for the administration of certain vmat2 inhibitors" on Fri, October 13, 2023

Filed a patent for "methods of synthesis" on Thu, August 3, 2023

Filed a patent for "crystalline forms" on Thu, July 27, 2023

Filed a patent for "deuterated compounds" on Tue, January 24, 2023

Filed a patent for "methods for the administration of crf antagonist" on Thu, March 30, 2023

Filed a patent for "methods for the administration of crf antagonist" on Mon, May 8, 2023

Filed a patent for "muscarinic receptor 4 antagonists and methods of use" on Mon, January 29, 2024

Filed a patent for "methods of screening for vmat2 inhibitors" on Fri, February 16, 2024

Filed a patent for "valbenazine compositions" on Fri, April 26, 2024

Filed a patent for "use of luvadaxistat for the treatment of cognitive impairment" on Wed, August 30, 2023

Filed a patent for "synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1s)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine" on Thu, July 18, 2024

Filed a patent for "valbenazine for use in the treatment of dyskinesia due to cerebral palsy" on Thu, December 28, 2023

Filed a patent for "valbenazine for use in the add-on treatment of schizophrenia" on Thu, December 28, 2023

Filed a patent for "muscarinic receptor 4 antagonists and methods of use" on Thu, April 27, 2023

Filed a patent for "vmat2 inhibitors and methods of use" on Wed, September 21, 2022

Filed a patent for "gpr52 modulators and methods of use" on Thu, July 27, 2023

Filed a patent for "methods for the administration of certain vmat2 inhibitors" on Tue, October 25, 2022

Filed a patent for "compounds and compositions as gpr52 modulators" on Wed, October 26, 2022

Filed a patent for "compounds and compositions as gpr52 modulators" on Wed, October 26, 2022

Filed a patent for "compounds and compositions as gpr52 modulators" on Wed, October 26, 2022

Filed a patent for "vmat2 inhibitors and methods of use" on Fri, November 18, 2022

Filed a patent for "synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1s)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine" on Thu, July 27, 2023